Skip to main content
. 2019 May 22;7:135. doi: 10.1186/s40425-019-0595-z

Fig. 1.

Fig. 1

Existing methods and proposed new classifier (a) Current approaches for neo-antigen detection involve three main stages: RNA sequencing, detection of mutations in tumor cells and the computation of MHC binding peptides in such mutated regions. We propose a new stage (b) the detection among the MHC binding peptides of those that manage to induce a T cell response